终末期肺病患者SPECT心肌灌注显像的可行性与准确性
本研究回顾性评估102例终末期肺病(ELD)患者使用瑞加诺生负荷SPECT心肌灌注显像(MPI)的可行性与准确性,所有患者均行负荷SPECT-MPI及冠状动脉造影。结果显示14%患者出现瑞加诺生相关症状,仅2%需医疗处理;冠状动脉造影发现20%患者存在阻塞性冠心病,其中5例SPECT-MPI异常,3例据此行PCI,14例阻塞性冠心病患者因SPECT-MPI正常而暂缓血运重建。结论认为瑞加诺生SPECT-MPI在ELD患者中耐受良好,可辅助肺移植前冠状动脉血运重建决策。
要点
- 瑞加诺生负荷SPECT-MPI在终末期肺病患者中耐受良好,仅2%需医疗处理。
- SPECT-MPI结果可辅助肺移植前冠状动脉血运重建决策。
- 20%患者冠状动脉造影发现阻塞性冠心病,其中5例SPECT-MPI异常。
核心结论
- 瑞加诺生负荷SPECT-MPI在终末期肺病患者中耐受良好,可辅助肺移植前冠状动脉血运重建决策。
研究设计与样本
- 回顾性研究,纳入2012年1月至2018年5月间102例因肺移植评估转诊的终末期肺病患者,均行负荷SPECT-MPI和冠状动脉造影。
主要发现
- 患者平均年龄57±6岁,所有患者均有严重肺功能损害。
- 负荷SPECT-MPI期间14例(14%)报告瑞加诺生相关症状,仅2例(2%)需医疗处理。
- 冠状动脉造影显示20例(20%)存在阻塞性冠心病。
- 阻塞性冠心病患者中5例SPECT-MPI异常,3例据此行PCI。
- 14例阻塞性冠心病患者因SPECT-MPI正常而暂缓血运重建。
关键数值与推荐
- 阻塞性冠心病定义为冠状动脉造影发现阻塞性病变,共20例(20%)。
- SPECT-MPI异常者5例,其中3例行PCI。
临床怎么用
- 对终末期肺病拟行肺移植评估的患者,可考虑使用瑞加诺生负荷SPECT-MPI评估冠心病。
- SPECT-MPI结果可帮助决定肺移植前是否行冠状动脉血运重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery disease (CAD) is associated with increased mortality in patients with chronic lung disease. However, non-invasive diagnostic of CAD is difficult, especially in patients with more advanced disease. Therefore, we aimed to assess the feasibility and accuracy of SPECT-myocardial perfusion imaging (MPI) stress testing with regadenoson in patients with end-stage lung disease (ELD) undergoing assessment of stable CAD. METHODS: Between January 2012 and May 2018, 102 patients with ELD, who were referred to our institution for lung transplant evaluation, were assessed retrospectively. All patients underwent both stress SPECT-MPI as well as coronary angiography. RESULTS: The mean age in our population was 57±6 years. All patients had severe pulmonary function impairment. During stress SPECT-MPI 14 patients (14%) reported regadenoson-related symptoms, but only 2 patients (2%) required medical treatment. Coronary angiography revealed obstructive CAD in 20 patients (20%). Among those, 5 patients had abnormal SPECT-MPI and PCI was performed in 3 patients accordingly. In 14 patients with obstructive CAD, revascularization was deferred based on normal SPECT-MPI findings. CONCLUSIONS: SPECT-MPI using regadenoson is well tolerated in patients with ELD and can help to make decisions about coronary revascularization before lung transplant.
引用
- Schiopu SRI, Zacherl M, Todica A, et al. Feasibility and accuracy of SPECT myocardial perfusion imaging in end-stage lung disease. J Nucl Cardiol. 2019. PMID: 31428982. doi:10.1007/s12350-019-01851-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。